Description
Flutafarm Femina (Flutamide) Tablets 0.125 g. №30
Composition
Active Ingredient: Each tablet contains Flutamide 0.125 g.
Mechanism of Action
Flutafarm Femina works as an androgen receptor antagonist, inhibiting androgen action in prostate cells. This mechanism leads to tumor regression and improved outcomes in patients with certain types of prostate cancer.
Pharmacological Properties
Flutamide, the active ingredient in Flutafarm Femina, exerts its effects by blocking androgen receptors, thereby interfering with the growth of prostate cancer cells.
Indications for Use
Indications: Flutafarm Femina is indicated for the treatment of specific types of prostate cancer.
Contraindications
Contraindications: Avoid using Flutafarm Femina if you have a known allergy to flutamide or if you are suffering from severe liver disease.
Side Effects
Common side effects of Flutafarm Femina may include gastrointestinal disturbances and liver function abnormalities. Regular monitoring is crucial to ensure the safety and efficacy of the treatment.
Usage Instructions
Dosage: The typical dosage is 1 tablet three times a day, as prescribed by a healthcare professional. It is important not to exceed the recommended dose.
Benefits Compared to Analogues
Flutafarm Femina has demonstrated efficacy in clinical trials for the treatment of prostate cancer, with a well-established safety profile and tolerability compared to other medications in its class.
Suitable Patient Groups
Flutafarm Femina is suitable for adult patients diagnosed with specific types of prostate cancer. Dosage adjustments may be necessary for elderly individuals or those with certain medical conditions; consult a healthcare provider for personalized recommendations.
Storage and Shelf Life
Store Flutafarm Femina in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond this date.
Packaging Description
Each package of Flutafarm Femina contains 30 tablets, with each tablet individually sealed to maintain product integrity and potency.
Clinical Evidence and Proven Effectiveness
Flutafarm Femina, with its active ingredient flutamide, has shown significant effectiveness in the treatment of prostate cancer. Clinical studies have illustrated that flutamide acts as an androgen receptor antagonist, leading to tumor regression and improved patient outcomes.
